Clinical Utility of Interleukins in Sepsis-Associated Acute Kidney Injury: Current Evidence and Future Perspectives

Authors

  • Khaled Mohammed Youssef , Ahmed Noaman , Yasser Abdelmonem Abdelsalam Hindy , Ahmed Abdulsaboor Mohamed and Usama Ragab Author

DOI:

https://doi.org/10.48047/2q3v0334

Keywords:

Sepsis-associated acute kidney injury; Interleukin-6; Interleukin-10

Abstract

Background: Sepsis-associated acute kidney injury (SA-AKI) is one of the most frequent and devastating complications of sepsis, 
substantially increasing morbidity, mortality, length of intensive care unit stay, and long-term risk of chronic kidney disease. Despite advances in supportive care, early diagnosis and accurate risk stratification remain challenging because conventional biomarkers, including serum creatinine and urine output, often fail to detect renal injury during

Downloads

Download data is not yet available.

References

Abe T, Yamakawa K, Ogura H, et al. Epidemiology of sepsis and septic shock in intensive care units between Sepsis-2 and Sepsis-3 populations: sepsis prognostication in intensive care unit and emergency room (SPICE-ICU). J Intensive Care. 2020;8:44.

Chang YM, Chou YT, Kan WC, Shiao CC. Sepsis and acute kidney injury: a review focusing on the bidirectional interplay. Int J Mol Sci. 2022;23

Downloads

Published

2024-11-20

How to Cite

Clinical Utility of Interleukins in Sepsis-Associated Acute Kidney Injury: Current Evidence and Future Perspectives (Khaled Mohammed Youssef , Ahmed Noaman , Yasser Abdelmonem Abdelsalam Hindy , Ahmed Abdulsaboor Mohamed and Usama Ragab , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 7821-7831. https://doi.org/10.48047/2q3v0334